Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q2 2017

2017-08-14
Price :
Published : Aug-2017
No. of Pages : 92

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q2 2017

Summary

GlobalData’s “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q2 2017”, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q2 2017. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in Q2 2017 with 1,110 deals worth USD91.3 billion, as compared 1,224 worth USD163.8 billion in Q2 2016. On a quarter-on-quarter basis, the number of deals and deal values decreased in Q2 2017, when compared to 1,185 deals worth USD95.9 billion in Q1 2017. The pharmaceutical and healthcare industry reported a decrease in upfront payments in licensing agreements with USD725.3m in Q2 2017, as compared USD1.1 billion in Q2 2016. On a quarter-on-quarter basis, the upfront payments reported a marginal increase in Q2 2017, when compared to USD723.6m in Q1 2017. Deals in oncology therapeutics market registered a decrease with 374 deals in Q2 2017, compared to 434 deals in Q1 2017. North America reported a decrease in the number of deals from 798 in Q1 2017 to 696 in Q2 2017.

Scope

– Analysis of the market trends for the pharmaceutical industry in the global arena.
– Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
– Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
– Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
– Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
– Analysis of partnership and licensing deals based on clinical stage of development of products.
– Summary of the pharmaceutical deals globally in the five quarters.
– Information on the top deals happened in the pharmaceutical industry.
– Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
– League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

– Enhance your decision making capability in a more rapid and time sensitive manner.
– Find out the major deal performing segments for investments in your industry.
– Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
– Identify companies that are aggressively looking to raise capital in the market
– Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
– Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
– Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
– Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
– Identify growth segments and opportunities in each region within the industry.
– Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Endocrinology Tests – Medical Devices Pipeline Assessment, 2018

Endocrinology Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Endocrinology Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Endocrinology Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Endocrinology Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Glo......
$4000

Hemostasis – Medical Devices Pipeline Assessment, 2018

Hemostasis - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hemostasis - Medical Devices Pipeline Assessment, 2018" provides an overview of Hemostasis currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. ......
$4000

Immunochemistry Analyzers – Medical Devices Pipeline Assessment, 2018

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Immunochemistry Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products. This report is prepared using data sourced from in-house databases, secondary and......
$4000

Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2018

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary......
$4000

Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2018

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products. This report is prepared using data sourced fr......
$4000

Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2018

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products. This report is prepared using data sourced from in-house databases, s......
$4000

Self Testing – Medical Devices Pipeline Assessment, 2018

Self Testing - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2018" provides an overview of Self Testing currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry e......
$2500

Hemostasis Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2018

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018" provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products. This ......
$2500

Hematology Reagents – Medical Devices Pipeline Assessment, 2018

Hematology Reagents - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hematology Reagents - Medical Devices Pipeline Assessment, 2018" provides an overview of Hematology Reagents currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Reagents pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Glo......
$2500

Anemia Tests – Medical Devices Pipeline Assessment, 2018

Anemia Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Anemia Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Anemia Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Anemia Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry e......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy